Showing results (131-140 of 277) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2015
First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced CancerGeoffrey I Shapiro, Katherine M Bell-McGuinn, Julian R Molina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitorRobert I Haddad, Lisa J Weinstein, Tad J Wieczorek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Cancer Research|June 17, 2024
Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor SensitivityAlexandre A da Costa, Ozge Somuncu, Ramya Ravindranathan, et al.
Molecular Cancer Therapeutics|May 7, 2020
Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734Chevaun D Morrison-Smith, Tatiana M Knox, Ivona Filic, et al.
NPJ Breast Cancer|April 26, 2025
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatmentAyako Nakashoji, Atrayee Bhattacharya, Hiroki Ozawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2013
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistanceZhao Chen, Esra Akbay, Oliver Mikse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2012
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomasDavid S Hong, Razelle Kurzrock, Jeffrey G Supko, et al.
Molecular Cancer Research : MCR|November 29, 2022
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast CancerNami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi, et al.
Pageof 28